DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
DSM-265
2
Small molecule
Investigational
Unknown
Unknown
Malaria; Malaria, Falciparum; Malaria, Vivax
Dihydroorotate dehydrogenase inhibitor
DSM-265
×
Maximum Phase:
2
First Approval:
None
UNII:
0Q42P4YI6B
Molecule Type:
Small molecule
Molecular Formula:
C14H12F7N5S
Molecular Weight:
415.34
AlogP:
5.95
PSA:
55.11
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PALIFOSFAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Breast Neoplasms; Sarcoma; Small Cell Lung Carcinoma
DNA cross-linking agent
PALIFOSFAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
6A4U6NN813
Molecule Type:
Small molecule
Molecular Formula:
C4H11Cl2N2O2P
Molecular Weight:
221.02
AlogP:
0.74
PSA:
61.36
HBD:
3.0
HBA:
#RotB:
6.0
Source:
DB959
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Peroxisome proliferator-activated receptor delta agonist
DB959
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DE-104
2
Small molecule
Investigational
Unknown
Unknown
Glaucoma, Open-Angle; Ocular Hypertension
Rho-associated protein kinase inhibitor
DE-104
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD3199
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
AZD3199
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GEMCITABINE ELAIDATE
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GEMCITABINE ELAIDATE
×
Maximum Phase:
2
First Approval:
None
UNII:
231C73W7LG
Molecule Type:
Small molecule
Molecular Formula:
C27H43F2N3O5
Molecular Weight:
527.65
AlogP:
5.3
PSA:
116.67
HBD:
2.0
HBA:
#RotB:
18.0
Source:
DILMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Acute Lung Injury; Arthritis, Rheumatoid; Coronary Disease; Neuralgia; Pulmonary Disease, Chronic Obstructive
MAP kinase p38 alpha inhibitor
DILMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
Q3238VQW0N
Molecule Type:
Small molecule
Molecular Formula:
C23H19F3N4O3
Molecular Weight:
456.42
AlogP:
2.94
PSA:
100.27
HBD:
3.0
HBA:
#RotB:
6.0
Source:
BROSTALLICIN
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Liposarcoma, Myxoid; Triple Negative Breast Neoplasms
DNA disrupting agent
BROSTALLICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
RPC6R41K4I
Molecule Type:
Small molecule
Molecular Formula:
C30H35BrN12O5
Molecular Weight:
723.59
AlogP:
1.65
PSA:
229.62
HBD:
7.0
HBA:
#RotB:
12.0
Source:
CERAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma; Leukemia, Myeloid, Acute; Breast Neoplasms
Unknown
CERAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
ZZK8X1CR0R
Molecule Type:
Small molecule
Molecular Formula:
C20H41NO3
Molecular Weight:
343.55
AlogP:
4.33
PSA:
69.56
HBD:
3.0
HBA:
#RotB:
17.0
Source:
ONO-8539
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux; Urinary Bladder, Overactive
Prostanoid EP1 receptor antagonist
ONO-8539
×
Maximum Phase:
2
First Approval:
None
UNII:
94W010PZ1Z
Molecule Type:
Small molecule
Molecular Formula:
C25H28N2O5S2
Molecular Weight:
500.64
AlogP:
5.07
PSA:
96.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
ADAFOSBUVIR
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Renal Insufficiency; Hepatitis C, Chronic
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
ADAFOSBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
S83770Y75R
Molecule Type:
Small molecule
Molecular Formula:
C22H29FN3O10P
Molecular Weight:
545.46
AlogP:
0.98
PSA:
178.41
HBD:
4.0
HBA:
#RotB:
10.0
Source:
NAZARTINIB
2
Small molecule
Investigational
Unknown
Unknown
Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
NAZARTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
KE7K32EME8
Molecule Type:
Small molecule
Molecular Formula:
C26H31ClN6O2
Molecular Weight:
495.03
AlogP:
4.32
PSA:
83.36
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TALVIRALINE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
TALVIRALINE
×
Maximum Phase:
2
First Approval:
None
UNII:
XZ4KT6MO4X
Molecule Type:
Small molecule
Molecular Formula:
C15H20N2O3S2
Molecular Weight:
340.47
AlogP:
3.53
PSA:
50.8
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CASTOR OIL
2
Small molecule
Investigational
Unknown
Unknown
Premature Birth; Constipation
Unknown
CASTOR OIL
×
Maximum Phase:
2
First Approval:
None
UNII:
D5340Y2I9G
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLORINAB
2
Small molecule
Investigational
Unknown
Unknown
Abdominal Pain; Crohn Disease; Irritable Bowel Syndrome
Cannabinoid CB2 receptor agonist
OLORINAB
×
Maximum Phase:
2
First Approval:
None
UNII:
581F7DFA9B
Molecule Type:
Small molecule
Molecular Formula:
C18H23N5O3
Molecular Weight:
357.41
AlogP:
0.7
PSA:
106.98
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BI-2536
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms; Carcinoma, Non-Small-Cell Lung; Leukemia, Myeloid, Acute; Pancreatic Neoplasms; Prostatic Neoplasms; Small Cell Lung Carcinoma
Serine/threonine-protein kinase PLK1 inhibitor
BI-2536
×
Maximum Phase:
2
First Approval:
None
UNII:
4LJG22T9C6
Molecule Type:
Small molecule
Molecular Formula:
C28H39N7O3
Molecular Weight:
521.67
AlogP:
3.56
PSA:
102.93
HBD:
2.0
HBA:
#RotB:
7.0
Source:
SHP-627
2
Small molecule
Investigational
Unknown
Unknown
Scleroderma, Diffuse
Unknown
SHP-627
×
Maximum Phase:
2
First Approval:
None
UNII:
C6V7ZU2NPR
Molecule Type:
Small molecule
Molecular Formula:
C20H17NO5
Molecular Weight:
351.36
AlogP:
3.06
PSA:
84.86
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PLECONARIL
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Sepsis; Virus Diseases
VP1 capsid protein disrupting agent
PLECONARIL
×
Maximum Phase:
2
First Approval:
None
UNII:
9H4570Q89D
Molecule Type:
Small molecule
Molecular Formula:
C18H18F3N3O3
Molecular Weight:
381.35
AlogP:
4.68
PSA:
74.18
HBD:
0.0
HBA:
#RotB:
6.0
Source:
IP-2018
2
Small molecule
Investigational
Unknown
Unknown
Erectile Dysfunction
Unknown
IP-2018
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C16H17NO3
Molecular Weight:
271.32
AlogP:
2.45
PSA:
51.47
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CMX-2043
2
Small molecule
Investigational
Unknown
Unknown
Coronary Disease
Unknown
CMX-2043
×
Maximum Phase:
2
First Approval:
None
UNII:
83V80O4XY1
Molecule Type:
Small molecule
Molecular Formula:
C16H26N2O6S2
Molecular Weight:
406.53
AlogP:
1.64
PSA:
132.8
HBD:
4.0
HBA:
#RotB:
12.0
Source:
SOFINICLINE
2
Small molecule
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity; Diabetic Nephropathies; Diabetic Neuropathies; Neuralgia
Neuronal acetylcholine receptor; alpha4/beta2 agonist
SOFINICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
SQC232V4YY
Molecule Type:
Small molecule
Molecular Formula:
C10H11Cl2N3
Molecular Weight:
244.12
AlogP:
1.8
PSA:
28.16
HBD:
1.0
HBA:
#RotB:
1.0
Source:
LICOGLIFLOZIN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Kidney Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Polycystic Ovary Syndrome
Sodium/glucose cotransporter 1 inhibitor
LICOGLIFLOZIN
×
Maximum Phase:
2
First Approval:
None
UNII:
57J06X6EI0
Molecule Type:
Small molecule
Molecular Formula:
C23H28O7
Molecular Weight:
416.47
AlogP:
1.13
PSA:
108.61
HBD:
4.0
HBA:
#RotB:
5.0
Source:
PRX-03140
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Serotonin 4 (5-HT4) receptor partial agonist
PRX-03140
×
Maximum Phase:
2
First Approval:
None
UNII:
7QGN8QXG7I
Molecule Type:
Small molecule
Molecular Formula:
C19H27N3O3S
Molecular Weight:
377.51
AlogP:
2.96
PSA:
74.57
HBD:
2.0
HBA:
#RotB:
6.0
Source:
AXP-107-11
2
Small molecule
Investigational
Unknown
Unknown
Adenocarcinoma
Unknown
AXP-107-11
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFLORNITHINE HCL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EFLORNITHINE HCL
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BRIVUDINE
2
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Pancreatic Neoplasms; Virus Diseases
Unknown
BRIVUDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
2M3055079H
Molecule Type:
Small molecule
Molecular Formula:
C11H13BrN2O5
Molecular Weight:
333.14
AlogP:
-0.46
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
3.0
Source:
NEBENTAN
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Endothelin receptor ET-A antagonist
NEBENTAN
×
Maximum Phase:
2
First Approval:
None
UNII:
IJ670B0H4A
Molecule Type:
Small molecule
Molecular Formula:
C24H21N5O5S
Molecular Weight:
491.53
AlogP:
4.16
PSA:
125.42
HBD:
1.0
HBA:
#RotB:
9.0
Source:
CPG-52852
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Melanoma
Toll-like receptor 7 agonist
CPG-52852
×
Maximum Phase:
2
First Approval:
None
UNII:
6PJC3KPK6S
Molecule Type:
Small molecule
Molecular Formula:
C17H23N5O2S
Molecular Weight:
361.47
AlogP:
2.06
PSA:
102.9
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CXL-1020
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure
Unknown
CXL-1020
×
Maximum Phase:
2
First Approval:
None
UNII:
T7Q0XY74OK
Molecule Type:
Small molecule
Molecular Formula:
C7H9NO5S2
Molecular Weight:
251.28
AlogP:
-0.24
PSA:
100.54
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AZD9056
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
P2X purinoceptor 7 antagonist
AZD9056
×
Maximum Phase:
2
First Approval:
None
UNII:
F13K378W4L
Molecule Type:
Small molecule
Molecular Formula:
C24H35ClN2O2
Molecular Weight:
419.01
AlogP:
4.19
PSA:
61.36
HBD:
3.0
HBA:
#RotB:
10.0
Source:
DANUSERTIB
2
Small molecule
Investigational
Unknown
Unknown
Leukemia; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant
Serine/threonine-protein kinase Aurora inhibitor
DANUSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
M3X659D0FY
Molecule Type:
Small molecule
Molecular Formula:
C26H30N6O3
Molecular Weight:
474.57
AlogP:
2.64
PSA:
93.8
HBD:
2.0
HBA:
#RotB:
6.0
Source:
OMS405
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma agonist
OMS405
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPETIRIMOD ESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPETIRIMOD ESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H92K6N217F
Molecule Type:
Small molecule
Molecular Formula:
C15H23N5O4S
Molecular Weight:
369.45
AlogP:
2.22
PSA:
69.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BXT-51072
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BXT-51072
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPB-348
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPB-348
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
92
93
94
95
96
97
98
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA